[RGLS] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
12-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -8.11%
YoY- 47.21%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 6 18 18 18 6,778 18 -
PBT -6,947 -5,945 -4,893 -5,423 -5,015 -3,260 -8,502 -12.60%
Tax 10 -8 -131 87 1 56 61 -70.07%
NP -6,947 -5,937 -4,893 -5,423 -5,016 -3,260 -8,563 -13.02%
Tax Rate - - - - - - - -
Total Cost 6,947 5,943 4,911 5,441 5,034 10,038 8,581 -13.14%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 -98,950.00 -27,183.33 -30,127.78 -27,866.67 -48.10 -47,572.22 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -2.33 -2.47 -2.34 -2.60 -3.00 -3.14 -9.75 -61.52%
EPS Diluted -2.33 -2.47 -2.34 -2.60 -3.00 -3.14 -9.75 -61.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.